Product Information
NICOTINE 4 MG CHEWING GUM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2866 per EA under NDC 45802065125. Its NADAC has been published 151 times since Nov 15, 2023.
FDA first approved this application on Dec 15, 2016.
Strength
4 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802065125
Classification
Generic
Dosage Form
GUM, CHEWING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA206393FDA Approved
12/15/2016
On Market Since
8/14/2023
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 4 MG CHEWING GUM has been published 151 times since Nov 15, 2023, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2866 per EA |
|---|---|
| All-time high | $0.3335 (Feb 14, 2024) |
| All-time low | $0.2400 (Jul 17, 2024) |
| 52-week high | $0.2866 |
| 52-week low | $0.2687 |
| Median price | $0.2783 |
| Average price | $0.2776 |
| Largest weekly change | +26.6% (Aug 21, 2024) |
| Weeks tracked | 151 |
| Tracking since | Nov 15, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nicotine polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICOTINE 4 MG CHEWING GUM?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG CHEWING GUM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2866 per EA (NDC 45802065125), effective Sep 30, 2026.
How has the price of NICOTINE 4 MG CHEWING GUM changed over time?
Over the history we have for it, the NADAC for NICOTINE 4 MG CHEWING GUM has declined 3.0%. It has been tracked across 151 weekly CMS publications since Nov 15, 2023.
What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG CHEWING GUM?
Since Nov 15, 2023, the NADAC for NICOTINE 4 MG CHEWING GUM has ranged from a low of $0.2400 (Jul 17, 2024) to a high of $0.3335 (Feb 14, 2024), with a median of $0.2783 per EA.
Are there cheaper alternatives to NICOTINE 4 MG CHEWING GUM?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NICOTINE 4 MG CHEWING GUM in a comparable dosage form, but none are currently priced below it.
Who manufactures NICOTINE 4 MG CHEWING GUM?
NICOTINE 4 MG CHEWING GUM (NDC 45802065125) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.